Univercells Technologies and Repligen have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform into Univercells' scale-X bioreactors. This innovation enables frequent, noninvasive measurements of glucose and lactate, enhancing process control during viral vector and vaccine manufacturing. The enhanced data resolution facilitates optimization of feeding strategies and cell growth estimation, advancing process analytical technology (PAT) in bioprocessing.